ARCHER 3 Carotid Stent Trial

From Ask Dr Wiki

ARCHER 3 enrolled high-risk symptomatic and asymptomatic patients. ARCHER 3 demonstrated a 30-day death, stroke, or myocardial infarction incidence of 8.3% compared to 14.5% for a historical control group (high-risk surgical patients).